Cline Scientific AB (OSTO:CLINE B) Beneish M-Score: 0.00 (As of Jun. 30, 2026)


OSTO:CLINE B Cline Scientific AB OSTO:CLINE B
4 GF Score
Price kr0.07
View Full Analysis

What is Cline Scientific AB Beneish M-Score?

Cline Scientific AB OSTO:CLINE B 4 Beneish M-Score is 0.00 as of Jun. 30, 2026. GuruFocus rates OSTO:CLINE B with a GF Score™ of 4/100.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

The historical rank and industry rank for Cline Scientific AB's Beneish M-Score or its related term are showing as below:

During the past 9 years, the highest Beneish M-Score of Cline Scientific AB was 0.00. The lowest was 0.00. And the median was 0.00.


Cline Scientific AB Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Cline Scientific AB's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cline Scientific AB Beneish M-Score Chart

Cline Scientific AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only -4.88 -1.80 -8.58 0.00 0.00

Cline Scientific AB Semi-Annual Data
Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -8.58 0.00 0.00 0.00 0.00

OSTO:CLINE B vs VRTX, REGN, SGEN: Beneish M-Score Comparison

For the Biotechnology subindustry, Cline Scientific AB's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cline Scientific AB Beneish M-Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cline Scientific AB's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Cline Scientific AB's Beneish M-Score falls into.


OSTO:CLINE B
4GF Score
Cline Scientific AB OSTO:CLINE B
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cline Scientific AB Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Cline Scientific AB for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * +0.528 * +0.404 * +0.892 * +0.115 *
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * +4.679 * -0.327 *
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Dec22) TTM:
Total Receivables was kr0.11 Mil.
Revenue was kr0.00 Mil.
Gross Profit was kr4.10 Mil.
Total Current Assets was kr3.45 Mil.
Total Assets was kr22.72 Mil.
Property, Plant and Equipment(Net PPE) was kr0.02 Mil.
Depreciation, Depletion and Amortization(DDA) was kr0.01 Mil.
Selling, General, & Admin. Expense(SGA) was kr0.00 Mil.
Total Current Liabilities was kr1.80 Mil.
Long-Term Debt & Capital Lease Obligation was kr0.00 Mil.
Net Income was kr-3.15 Mil.
Gross Profit was kr0.00 Mil.
Cash Flow from Operations was kr-1.73 Mil.
Total Receivables was kr0.25 Mil.
Revenue was kr0.00 Mil.
Gross Profit was kr2.83 Mil.
Total Current Assets was kr4.08 Mil.
Total Assets was kr18.82 Mil.
Property, Plant and Equipment(Net PPE) was kr0.04 Mil.
Depreciation, Depletion and Amortization(DDA) was kr0.01 Mil.
Selling, General, & Admin. Expense(SGA) was kr0.00 Mil.
Total Current Liabilities was kr0.54 Mil.
Long-Term Debt & Capital Lease Obligation was kr0.00 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(0.105 / 0) / (0.251 / 0)
= /
=

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(2.825 / 0) / (4.104 / 0)
= /
=

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (3.454 + 0.022) / 22.721) / (1 - (4.079 + 0.035) / 18.817)
=0.847014 / 0.781368
=

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=0 / 0
=

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(0.013 / (0.013 + 0.035)) / (0.013 / (0.013 + 0.022))
=0.270833 / 0.371429
=

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(0 / 0) / (0 / 0)
= /
=

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((0 + 1.804) / 22.721) / ((0 + 0.542) / 18.817)
=0.079398 / 0.028804
=

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-3.148 - 0 - -1.727) / 22.721
=-0.062541

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of 0.00 mean?
Cline Scientific AB (OSTO:CLINE B) has a Beneish M-Score of 0.00 as of Jun. 30, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Cline Scientific AB and its competitors.
Is Cline Scientific AB's Beneish M-Score too high?
Cline Scientific AB's current Beneish M-Score is 0.00. Overall, Cline Scientific AB has a GF Score™ of 4/100, reflecting its overall financial health beyond just this single metric.
How does Cline Scientific AB's Beneish M-Score compare to VRTX and REGN?
Cline Scientific AB's Beneish M-Score of 0.00 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Biotechnology company?
A good Beneish M-Score depends on the Biotechnology industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Cline Scientific AB and its competitors. Cline Scientific AB's current Beneish M-Score is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cline Scientific AB stock overvalued right now?
Cline Scientific AB (OSTO:CLINE B) has a current Beneish M-Score of 0.00. The current Beneish M-Score is 0.00. Cline Scientific AB's overall GF Score™ is 4/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Cline Scientific AB (OSTO:CLINE B), the current Beneish M-Score is 0.00 as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cline Scientific AB Business Description

Address Vastra Gotalands Lan, 2C Argongatan, Molndal, SWE, 43153
Cline Scientific AB develops and markets products for biomedical research based on proprietary nanotechnology. Its products include unique surfaces for use in stem cell & cancer research and customized nanoparticles for use in biomedical applications.
4GF Score

Get the complete analysis for OSTO:CLINE B

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr0.07
Price